These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 34515401)

  • 1. An Organic Nanotherapeutic Agent Self-Assembled from Cyanine and Cu (II) for Combined Photothermal and Chemodynamic Therapy.
    Li X; Xi D; Yang M; Sun W; Peng X; Fan J
    Adv Healthc Mater; 2021 Oct; 10(20):e2101008. PubMed ID: 34515401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional CuFe
    Chen N; Li Y; Li H; Wang Y; Zeng Y; Zhang M; Pan Z; Chen Z; Liang W; Huang J; Zhang K; Liu X; He Y
    Colloids Surf B Biointerfaces; 2023 Sep; 229():113445. PubMed ID: 37441838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copperphosphotungstate Doped Polyanilines Nanorods for GSH-Depletion Enhanced Chemodynamic/NIR-II Photothermal Synergistic Therapy.
    Ye S; Xiao H; Chen J; Zhang D; Qi L; Peng T; Gao Y; Zhang Q; Qu J; Wang L; Liu R
    Int J Nanomedicine; 2023; 18():1245-1257. PubMed ID: 36937549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fe-Doped Polyoxometalate as Acid-Aggregated Nanoplatform for NIR-II Photothermal-Enhanced Chemodynamic Therapy.
    Shi Y; Zhang J; Huang H; Cao C; Yin J; Xu W; Wang W; Song X; Zhang Y; Dong X
    Adv Healthc Mater; 2020 May; 9(9):e2000005. PubMed ID: 32181991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper-based theranostic nanocatalysts for synergetic photothermal-chemodynamic therapy.
    Zuo W; Fan Z; Chen L; Liu J; Wan Z; Xiao Z; Chen W; Wu L; Chen D; Zhu X
    Acta Biomater; 2022 Jul; 147():258-269. PubMed ID: 35605954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasmall Gold-Coated Mesoporous Polydopamine Nanoprobe to Enhance Chemodynamic Therapy by Self-Supplying H
    Wang Z; Shi Y; Shi Y; Zhang J; Hao R; Zhang G; Zeng L
    ACS Appl Mater Interfaces; 2022 Dec; 14(49):54478-54487. PubMed ID: 36448730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prussian Blue-Derived Nanoplatform for In Situ Amplified Photothermal/Chemodynamic/Starvation Therapy.
    Liang J; Sun Y; Wang K; Zhang Y; Guo L; Bao Z; Wang D; Xu H; Zheng J; Yuan Y
    ACS Appl Mater Interfaces; 2023 Apr; 15(14):18191-18204. PubMed ID: 36975190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox homeostasis disruptors enhanced cuproptosis effect for synergistic photothermal/chemodynamic therapy.
    Liu Z; Ling J; Wang N; Ouyang XK
    J Colloid Interface Sci; 2025 Jan; 678(Pt A):1060-1074. PubMed ID: 39236435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ellagic acid-Fe@BSA nanoparticles for endogenous H
    Tian Q; An L; Tian Q; Lin J; Yang S
    Theranostics; 2020; 10(9):4101-4115. PubMed ID: 32226542
    [No Abstract]   [Full Text] [Related]  

  • 10. Cu-Chelated polydopamine nanoparticles as a photothermal medium and "immunogenic cell death" inducer for combined tumor therapy.
    Xu N; Hu A; Pu X; Wang J; Liao X; Huang Z; Yin G
    J Mater Chem B; 2022 Apr; 10(16):3104-3118. PubMed ID: 35348176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearable Theranostic Platform with a pH-Independent Chemodynamic Therapy Enhancement Strategy for Synergetic Photothermal Tumor Therapy.
    Chen Q; Luo Y; Du W; Liu Z; Zhang S; Yang J; Yao H; Liu T; Ma M; Chen H
    ACS Appl Mater Interfaces; 2019 May; 11(20):18133-18144. PubMed ID: 31046230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photothermal nanozymes to self-augment combination cancer therapy by dual-glutathione depletion and hyperthermia/acidity-activated hydroxyl radical generation.
    Wang TH; Shen MY; Yeh NT; Chen YH; Hsu TC; Chin HY; Wu YT; Tzang BS; Chiang WH
    J Colloid Interface Sci; 2023 Nov; 650(Pt B):1698-1714. PubMed ID: 37499626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Microenvironment-Responsive Biodegradable Nanomedicine for Self-Enhanced Synergistic Chemo-, Photothermal, and Chemodynamic Therapy.
    Tang HX; He ZH; Liu CG; Zheng XK; Zhang ZJ
    ACS Appl Mater Interfaces; 2024 Oct; 16(39):52023-52035. PubMed ID: 39303011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H
    Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSH-Activatable Metal-Phenolic Networks for Photothermal-Enhanced Chemotherapy and Chemodynamic Therapy.
    Chen W; Yang M; Li J; Chen Z; Hu L; Zhang J; Cai L; Qiu L; Chen J
    J Funct Biomater; 2023 Aug; 14(9):. PubMed ID: 37754850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hollow Co
    Jiang Y; Lu H; Yuan X; Zhang Y; Lei L; Li Y; Sun W; Liu J; Scherman D; Liu Y
    J Mater Chem B; 2022 Oct; 10(39):8082-8093. PubMed ID: 36128978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-responsive and NIR-driven free radical nanoamplifier with glutathione depletion for enhanced tumor-specific photothermal/thermodynamic/chemodynamic synergistic Therapy.
    Chen F; Zhang X; Wang Z; Xu C; Hu J; Liu L; Zhou J; Sun B
    Biomater Sci; 2022 Oct; 10(20):5912-5924. PubMed ID: 36040793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutual Benefit between Cu(II) and Polydopamine for Improving Photothermal-Chemodynamic Therapy.
    Zhang WX; Hao YN; Gao YR; Shu Y; Wang JH
    ACS Appl Mater Interfaces; 2021 Aug; 13(32):38127-38137. PubMed ID: 34347422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferrocene-based multifunctional nanoparticles for combined chemo/chemodynamic/photothermal therapy.
    Yang J; Yang L; Li Q; Zhang L
    J Colloid Interface Sci; 2022 Nov; 626():719-728. PubMed ID: 35820207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-situ fabrication of novel Au nanoclusters-Cu
    Yang Z; Zhao Z; Cheng H; Shen Y; Xie A; Zhu M
    J Colloid Interface Sci; 2023 Jul; 641():215-228. PubMed ID: 36933468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.